GlassScriptPhysician profile
Kerry Daniels
NPI 1881850659
$1,587.61
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,572 · 2022: $15.21.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $424.08 | 2021 | |
| Sun Pharmaceutical Industries INC. | $329.54 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $143.88 | 2021 | |
| Novartis Pharmaceuticals Corporation | $130.79 | 2021-2022 | |
| Galderma Laboratories, L.P. | $116.79 | 2021 | |
| Amgen INC. | $77.58 | 2021 | |
| Almirall LLC | $68.33 | 2021 | |
| Lilly USA, LLC | $62.68 | 2021 | |
| Pfizer INC. | $59.53 | 2021 | |
| Vyne Pharmaceuticals INC. | $53.91 | 2021 | |
| Janssen Biotech, INC. | $41.43 | 2021 | |
| Allergan, INC. | $19.64 | 2021 | |
| Ucb, INC. | $16.63 | 2021 | |
| Genentech USA, INC. | $16.03 | 2021 | |
| Nabriva Therapeutics, Plc | $13.42 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.35 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.